BioNTech AG, a growing biotechnology company focused on precise immunotherapies for the treatment of cancer and infectious disease, has entered into a multi-year research and development collaboration with Pfizer to develop mRNA-based vaccines for prevention of influenza (flu). Under the terms of the agreement, BioNTech and Pfizer will jointly conduct research and development activities to…